The presence of antibodies against HIV peptides in the sera of alloimmune mice and thalassemic patients is due to a polyclonal activation mechanism

Clinical Immunology and Immunopathology

Volumn 84, Issue 2, 1997, Pages 202-207

  Fraziano, Maurizio ^a   Montesano, Carla ^a   Lombardi, Valter R M ^b   Marchione, Orazio P ^c   Colizzi, Vittorio ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b Eurospes   (Spain)

^c Laboratory of Clinical Diagnosis PRODA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; POLYCLONAL ANTIBODY; SYNTHETIC PEPTIDE; VIRUS PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL MODEL; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THALASSEMIA; VIRUS INFECTION;

EID: 0031214757     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1997.4394     Document Type: Article

References (32)

1. Habeshaw J., Hounsell E., Dalgleish A. G. Does the HIV envelope induce a chronic graft versus host disease? Immunol. Today. 13:1992;207-210.
2. Kion T. A., Hoffmann G. W. Anti-HIV and anti-anti-HIV antibodies in alloimmune and autoimmune mice. Science. 253:1991;1138-1140.
3. Lombardi V., Rossi P., Romiti L., Mattei M., Mariani F., Poccia F., Colizzi V. HIV gp120 epitope immunodominance in MRL/lpr mice. AIDS Res. Hum. Retroviruses. 8:1992;1081-1082.
4. Lombardi V., Placido R., Scarlatti G., Romiti M. L., Mattei M., Mariani F., Poccia F., Rossi P., Colizzi V. Epitope specificity, antibody dependent cellular cytotoxicity and neutralizing activity of anti HIV-1 antibodies present in autoimmune MRL/lpr mice. J. Infect. Dis. 167:1993;1267-1273.
5. Hoffmann G. W., Kion T. A., Grant M. D. An idiotypic network model of AIDS immunopathogenesis. Proc. Natl. Acad. Sci. USA. 88:1991;3060-3064.
6. Susal C., Kropelin M., Daniel V., Opelz G. Molecular mimicry between HIV-1 and antigen receptor molecules: A clue to the pathogenesis of AIDS. Vox Sang. 65:1993;10-17.
7. Susal C., Hoffmann G. W., Daniel V., Grant M., Opelz G. Complementarities and network interactions in AIDS. J. Autoimmun. 6:1993;601-610.
8. Sheikh M. J., Ongradi J., Austen B. M., Dalgleish A. G. The gp120 envelope of HIV-1 binds peptides in a similar manner to human leukocyte antigens. AIDS. 9:1995;1229-1235.
9. Grassi F., Menervi R., Gullberg M., Lopalco L., Rossi G. B., Lanza P., De Santis C., Brattsand G., Buttó S., Ginelli E., Beretta A., Siccardi A. G. Human immunodeficiency virus type 1 gp120 mimics a hidden monomorphic epitope borne by class I major histocompatibility complex heavy chains. J. Exp. Med. 174:1991;53-62.
10. Young J. A. T. HIV and HLA similarity. Nature. 333:1988;215.
11. Cordiali P., Balzarotti V., Morante S., Parisi V., Pugliese O., Camponeschi B., Colizzi V. Convergent evolution in the homology between HIV gp120 and HLA class II molecules. AIDS Res. Hum. Retroviruses. 8:1992;1561-1565.
12. Aizawa T., Maruyama K., Kondo H., Toshikawa K. Expression of necdin, an embryonal carcinoma derived nuclear protein, in developing mouse brain. Dev. Brain Res. 68:1992;265-274.
13. Anderson D. C., Barry M. E., Buchanan T. M. Exact definition of species specific and cross-reactive epitopes of 65 kDA protein of Mycobacterium leprae using synthetic peptides. J. Clin. Immunol. 141:1988;607-613.
14. Yoshikai S., Sasaki H., Doh-Ura K., Furuya H., Sakaki Y. Genomic organization of the human amyloid beta-protein precursor gene. Gene. 87:1990;257-263.
15. Traversari C., van der Bruggen P., Luescher I. F., Lurquin C., Chomez P., van Pel A., De Plaen E., Amar-Costesec A., Boon T. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2E. J. Exp. Med. 176:1992;1453-1457.
16. Ho D. D., Kaplan C. J., Rackauskas I. E., Gurney M. E. Second conserved domain of gp120 is important for HIV infectivity and antibody neutralization. Science. 239:1988;1021-1023.
17. Ronco J., Charbit A., Dedieu J. F., Mancini M., Michel M. L., Henin Y., O'Challagan D., Kaczorek M., Girard M., Hofnung M. Is there a neutralising epitope in the second conserved domain of HIV-1 envelope protein? AIDS Res. Hum. Retroviruses. 7:1991;1-2.
18. Romeo M. A., Russo Mancuso G., Mauro L., Sciotto A., Romeo M. A., Di Gregorio F., Giammanco G., Schiliró G. Immunological changes in beta-thalassemia major patients positive for HTLV-III antibodies. Eur. J. Epidemiol. 3:1987;451-453.
19. Lombardi G., Matera R., Minervini M. M., Cascavilla N., D'Arcangelo P., Carotenuto M., Di Giorgio G., Musto P. Serum levels of cytokines and soluble antigens in polytransfused patients with beta-thalassemia major: Relationship to immune status. Haematologica. 79:1994;406-412.
20. Fraziano M., Montesano C., Lombardi V. R. M., Sammarco I., De Pisa F., Mattei M., Valesini G., Pittoni V., Colizzi V. Epitope specificity of anti-HIV antibodies in human and murine autoimmune diseases. AIDS Res. Hum. Retroviruses. 12:1996;491-496.
21. Bermas B. L., Petri M., Berzofsky J. A., Waisman A., Shearer G. M., Mozes E. Binding of glycoprotein gp120 and peptides from the HIV-1 envelope by autoantibodies in mice with experimentally induced systemic lupus erythematosus and in patients with the disease. AIDS Res. Hum. Retroviruses. 10:1994;1071-1077.
22. Talal N., Dauphinée M. J., Dang H., Alexander S. S., Hart D. J., Garry R. F. Detection of serum antibodies to retroviral proteins in patients with primary Sjogren syndrome autoimmune exocrinopathy. Arthritis Rheum. 33:1990;774-781.
23. Ter-Grigorov V. S., Krifuks O., Liubashevsky E., Nyska A., Trainin Z., Toder V. A new transmissible AIDS-like disease in mice induced by alloimmune stimuli. Nature Med. 3:1997;37-41.
24. Veljkovic V., Metlas R. Sequence similarity between human immunodeficiency virus type 1 envelope protein (gp120) and human proteins: A new hypothesis on protective antibody production. Immunol. Lett. 26:1990;193-196.
25. Metlas R., Veljkovic V., Paladini R. D., Pongor S. Protein and DNA-sequence homology between the V3 loop of human immunodeficiency virus type 1 envelope protein gp120 and immunoglobulin variable regions. Biochem. Biophys. Res. Commun. 179:1991;1056-1062.
26. Susal C., Daniel V., Opelz G. Does AIDS emerge from a disequilibrium between two complementary groups of molecules that mimic MHC? Immunol. Today. 17:1996;114-119.
27. Kiprov D. D., Sheppard H. W., Hanson C. V. Alloimmunization to prevent AIDS? Science. 263:1994;737-738.
28. Arhur L. O., Bess J. W. Jr., Sowder R. C. II, Benveniste R. E., Mann D. L., Chermann J. C., Henderson L. E. Cellular proteins bound to immunodeficiency viruses: Implications for pathogenesis and vaccines. Science. 258:1992;1935-1938.
29. Stott E. J. Anti-cell antibodies in macaques. Nature. 353:1991;393.
30. Langlois A. J., Weinhold K. J., Matthews K. J., Greenberg M. L., Bolognesi D. P. Detection of anti-human cell antibodies in sera from macaques immunized with whole inactivated virus. AIDS Res. Hum. Retroviruses. 8:1992;1641-1652.
31. Langlois A. J., Weinhold K. J., Matthews K. J., Greenberg M. L., Bolognesi D. P. The ability of certain SIV vaccines to provoke reactions against normal cells. Science. 255:1992;292-293.
32. Chan W. L., Rodgers A., Hancock R. D., Taffs F., Kitchin P., Farrar G., Liew F. Y. Protection in simian immunodeficiency virus-vaccinated monkeys correlates with anti-HLA class I antibody response. J. Exp. Med. 176:1992;1203-1207.